ABSTRACT: The selective inhibitor of osteoclastic V-ATPase (2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-2,4-pentadienamide (SB 242784), member of the indole class of V-ATPase inhibitors, is expected to target the membrane-bound domain of the enzyme. A structural study of the interaction of this inhibitor with the lipidic environment is an essential step in the understanding of the mechanism of inhibition. In this work, a comprehensive study of the relevant features of this interaction was performed. Inhibitor partition coefficients to lipid vesicles as well as its transverse location, orientation (order parameters), and dynamics while bound to bilayers were determined through photophysical techniques,...
The Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum is inhibited by a variety of hydrophobic, ...
AbstractBone resorption by the osteoclast is dependent on acidification of the bone surface by a vac...
A potent and selective inhibitor of the osteoclastic V-H(+)-ATPase, (2Z,4E)-5-(5,6-dichloro-2-indoly...
ABSTRACT The osteoclast variant of the vacuolar H1-ATPase (V-ATPase) is a potential therapeutic targ...
AbstractThe osteoclast variant of the vacuolar H+-ATPase (V-ATPase) is a potential therapeutic targe...
Amides of (2Z,4E)-5-[(5,6-dichloroindol-2-yl)]-2-methoxy-N-[3-[4-(3-(carboxymethoxy)phenyl)] piperaz...
In the last decades osteoporosis has become a major subject on the field of drug discovery and desig...
In the last decades, osteoporosis has become a major subject in the field of drug discovery and desi...
Treatment with phosphatidylinositol-specific phospholipase C of rat osseous plate membranes released...
AbstractTreatment with phosphatidylinositol-specific phospholipase C of rat osseous plate membranes ...
Osteoclasts resorb bone by expressing proton-pumping vacuolar type H+-ATPases (V-ATPases) on their c...
The investigation of V-ATPases as potential therapeutic drug targets and hence of their specific inh...
For bone resorption, vacuolar-type H+-ATPases (V-ATPases) on the plasma membranes of osteoclasts aci...
The V-ATPases are ATP-dependent proton pumps, found in virtually all cells, responsible for acidific...
AbstractTwo spin-labelled derivatives of the 5-(2-indolyl)-2,4-pentadienoyl class of inhibitors of t...
The Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum is inhibited by a variety of hydrophobic, ...
AbstractBone resorption by the osteoclast is dependent on acidification of the bone surface by a vac...
A potent and selective inhibitor of the osteoclastic V-H(+)-ATPase, (2Z,4E)-5-(5,6-dichloro-2-indoly...
ABSTRACT The osteoclast variant of the vacuolar H1-ATPase (V-ATPase) is a potential therapeutic targ...
AbstractThe osteoclast variant of the vacuolar H+-ATPase (V-ATPase) is a potential therapeutic targe...
Amides of (2Z,4E)-5-[(5,6-dichloroindol-2-yl)]-2-methoxy-N-[3-[4-(3-(carboxymethoxy)phenyl)] piperaz...
In the last decades osteoporosis has become a major subject on the field of drug discovery and desig...
In the last decades, osteoporosis has become a major subject in the field of drug discovery and desi...
Treatment with phosphatidylinositol-specific phospholipase C of rat osseous plate membranes released...
AbstractTreatment with phosphatidylinositol-specific phospholipase C of rat osseous plate membranes ...
Osteoclasts resorb bone by expressing proton-pumping vacuolar type H+-ATPases (V-ATPases) on their c...
The investigation of V-ATPases as potential therapeutic drug targets and hence of their specific inh...
For bone resorption, vacuolar-type H+-ATPases (V-ATPases) on the plasma membranes of osteoclasts aci...
The V-ATPases are ATP-dependent proton pumps, found in virtually all cells, responsible for acidific...
AbstractTwo spin-labelled derivatives of the 5-(2-indolyl)-2,4-pentadienoyl class of inhibitors of t...
The Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum is inhibited by a variety of hydrophobic, ...
AbstractBone resorption by the osteoclast is dependent on acidification of the bone surface by a vac...
A potent and selective inhibitor of the osteoclastic V-H(+)-ATPase, (2Z,4E)-5-(5,6-dichloro-2-indoly...